Goldman Sachs’s DermTech, Inc. Common Stock DMTK Stock Holding History

Goldman Sachs’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,683	Closed	-$39.3K	–	6162
2023 Q1	$39.3K	Sell	10,683 -47,481	-82%	-$200K	﹤0.01%	5587
2022 Q4	$103K	Sell	58,164 -30,481	-34%	-$81.1K	﹤0.01%	5474
2022 Q3	$352K	Sell	88,645 -19,215	-18%	-$118K	﹤0.01%	5206
2022 Q2	$597K	Sell	107,860 -81,990	-43%	-$671K	﹤0.01%	4961
2022 Q1	$2.79M	Buy	189,850 +87,759	+86%	+$1.17M	﹤0.01%	3935
2021 Q4	$1.61M	Buy	102,091 +73,593	+258%	+$1.77M	﹤0.01%	4428
2021 Q3	$915K	Buy	28,498 +5,536	+24%	+$194K	﹤0.01%	4818
2021 Q2	$954K	Buy	22,962 +6,275	+38%	+$258K	﹤0.01%	4796
2021 Q1	$847K	Buy	+16,687	New	+$873K	﹤0.01%	4733
2020 Q4	–	Sell	-18,287	Closed	-$219K	–	5769
2020 Q3	$219K	Buy	+18,287	New	+$212K	﹤0.01%	4876
2020 Q2	–	Sell	-24,815	Closed	-$279K	–	5538
2020 Q1	$279K	Buy	+24,815	New	+$305K	﹤0.01%	4550

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs's DMTK Position: Q2 2023 in Review

Goldman Sachs sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2023, closing a stake of 10,683 shares — an estimated $39.3K sold.

Goldman Sachs first reported a position in DMTK in Q1 2020 and held it in 11 quarters. The position peaked at $2.79M in Q1 2022. 85 funds tracked by Wall St. Rank hold DMTK as of Q2 2023.

Goldman Sachs reported no remaining DermTech, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Goldman Sachs sold 10,683 DermTech, Inc. Common Stock shares in Q2 2023, an estimated $39.3K.
Goldman Sachs first reported a position in DermTech, Inc. Common Stock in Q1 2020 and held it in 11 quarters.
Goldman Sachs's DermTech, Inc. Common Stock position peaked at $2.79M in Q1 2022.
85 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.